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Background: We evaluated whether the presence of atrial fibrillation (AF) influences the indices obtained from cardiopulmonary exercise testing 
(CPX), which are known to reflect cardiopulmonary function during exercise in cardiac patients.
Methods: A total of 554 consecutive patients with organic cardiac disease (63.5 ± 10.5 years) underwent CPX. The cardiac rhythm was 
sinus rhythm (SR) in 482 and AF in 72 patients. Etiology was coronary artery disease in 339 (61.2%), valvular disease in 161 (29.1%), dilated 
cardiomyopathy in 35 (6.3%), and hypertrophic cardiomyopathy in 19 (3.4%) patients.
Results: As compared to patents with SR, those with AF had lower values of LVEF (53.8 ± 15.4 vs 59.9 ± 15.4 %, p=0.002), peakVO2 (14.8 ± 4.9 
vs 18.7 ± 5.2 ml/min/kg, p<0.0001), ΔVO2/ΔWR (7.4 ± 3.0 vs 9.4 ± 2.1 ml/min/W, p<0.0001), and O2 pulse at peak (6.3 ± 2.4 vs 9.3 ± 2.7 ml/
beat, p<0.0001), and higher values of LAD (56.1 ± 17.4 vs 37.7 ± 7.5 mm, p<0.0001) and VE-VCO2 slope (38.0 ± 12.1 vs 31.9 ± 7.1, p<0.0001). 
A stepwise regression analysis including age, gender, medications, etiology of heart disease, and echocardiography parameters revealed that the 
cardiac rhythm is a significant predictor influencing peakVO2, ΔVO2/ΔWR, O2-pulse, and VE-VCO2 slope.
Conclusions: The present findings suggest that the presence of AF significantly impairs cardiopulmonary function during exercise in patients with 
organic cardiac disease.
